General
Preferred name
TRIOXSALEN
Synonyms
Nsc 7104 ()
Trimethylpsoralen ()
Trioxysalen ()
Trisoralen ()
Trioxsalen ()
TMP ()
4,5',8-trimethylpsoralen ()
NSC-71047 ()
Trioxisaleno ()
Trioxysalene ()
Tmp (psoralen) ()
P&D ID
PD002100
CAS
3902-71-4
Tags
drug
available
Approved by
FDA
First approval
1964
Drug Status
approved
withdrawn
Max Phase
4.0
Drug indication
psoriasis
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Trioxsalen is a derivative of the photoactive probe psoralen. Trioxsalen is a pigmenting photosensitizing agent used in conjunction with ultraviolet light in the treatment of vitiligo. (Enamine Bioactive Compounds)
DESCRIPTION Trioxsalen (Trioxysalen) is a furanocoumarin and a psoralen derivative, in conjunction with UV-A for phototherapy treatment of vitiligo and hand eczema. After photoactivation it creates interstrand cross-links in DNA, which can cause programmed cell death. (TargetMol Bioactive Compound Library)
Cell lines
1
Organisms
0
Compound Sets
21
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
TargetMol Bioactive Compound Library
The Spectrum Collection
Withdrawn 2.0
External IDs
36
Properties
(calculated by RDKit )
Molecular Weight
228.08
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
0
Ring Count
3
Aromatic Ring Count
3
cLogP
3.46
TPSA
43.35
Fraction CSP3
0.21
Chiral centers
0.0
Largest ring
6.0
QED
0.55
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
DNA intercalator
DNA synthesis inhibitor
Target
DNA
DHFR
DNA alkylator/crosslinker
Indication
vitiligo, eczema
ATC
D05AD01
D05BA01
Pathway
Cell Cycle/Checkpoint
DNA Damage/DNA Repair
Metabolism
Cell Cycle/DNA Damage
Source data